Literature DB >> 17044196

The pathogenesis of mesothelioma.

Michele Carbone1, Carlos W M Bedrossian.   

Abstract

Widespread asbestos exposure during the past century has been linked to the dramatic increased incidence of malignant mesothelioma (MM), a malignancy that was so rare until 1950-1960 that some pathologists questioned its existence. Although asbestos has been clearly linked to MM pathogenesis, until recently the mechanisms of asbestos carcinogenesis in humans have remained obscure. Recent results revealed that asbestos carcinogenesis in humans and in rodents is linked to the activation of the AP-1 pathway, which induces cell division, and to the secretion of TNF-alpha (and the expression of its receptor) by mesothelial cells and by nearby macrophages exposed to asbestos. In mesothelial cells, TNF-alpha signaling through NF-kappaB activation prevents apoptosis and cell death, allowing mesothelial cells to survive the genetic damage induced by asbestos and divide. In addition, mutagenic oxygen radicals released mainly by lung macrophages may contribute to asbestos carcinogenesis. Very recent results indicate that mineral fiber carcinogenesis can be influenced by genetics and microbial infections. Genetic susceptibility to the mineral fiber erionite has been demonstrated in some Turkish families and causes a MM epidemic in Cappadocia, Turkey. In these mesothelioma families, exposure to minimal amounts of erionite or asbestos appears sufficient to cause mesothelioma. Recent results (Kroczynska B, et al: Proc Natl Acad Sci USA, in press), demonstrate that SV40 and crocidolite asbestos are cocarcinogens and that, in the presence of SV40, significantly lower amounts of asbestos suffice to induce MM. These findings indicate that the risk varies among asbestos- and erionite-exposed individuals because of their genetic background or because of exposure to other carcinogens. Moreover, these data provide a rationale for the observation that only a fraction of heavily exposed asbestos workers developed mesothelioma, and novel targets for prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044196     DOI: 10.1053/j.semdp.2006.08.002

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  25 in total

Review 1.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

Review 2.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

3.  Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.

Authors:  Haining Yang; Zeyana Rivera; Sandro Jube; Masaki Nasu; Pietro Bertino; Chandra Goparaju; Guido Franzoso; Michael T Lotze; Thomas Krausz; Harvey I Pass; Marco E Bianchi; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

4.  Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways.

Authors:  Pamela E Blackshear; Arun R Pandiri; Thai-Vu T Ton; Natasha P Clayton; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2013-08-26       Impact factor: 1.902

5.  Does Chromothripsis Make Mesothelioma an Immunogenic Cancer?

Authors:  Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  J Thorac Oncol       Date:  2018-12-28       Impact factor: 15.609

6.  A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.

Authors:  Sandra Pastorino; Yoshie Yoshikawa; Harvey I Pass; Mitsuru Emi; Masaki Nasu; Ian Pagano; Yasutaka Takinishi; Ryuji Yamamoto; Michael Minaai; Tomoko Hashimoto-Tamaoki; Masaki Ohmuraya; Keisuke Goto; Chandra Goparaju; Kavita Y Sarin; Mika Tanji; Angela Bononi; Andrea Napolitano; Giovanni Gaudino; Mary Hesdorffer; Haining Yang; Michele Carbone
Journal:  J Clin Oncol       Date:  2018-10-30       Impact factor: 44.544

Review 7.  A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer.

Authors:  Mark J Hoenerhoff; Hue Hua Hong; Tai-vu Ton; Stephanie A Lahousse; Robert C Sills
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

8.  Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells.

Authors:  Shuhei Hakiri; Hirotaka Osada; Futoshi Ishiguro; Hideki Murakami; Yuko Murakami-Tonami; Kohei Yokoi; Yoshitaka Sekido
Journal:  Cancer Sci       Date:  2015-06-25       Impact factor: 6.716

9.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12

Review 10.  Malignant mesothelioma.

Authors:  Alastair J Moore; Robert J Parker; John Wiggins
Journal:  Orphanet J Rare Dis       Date:  2008-12-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.